Avidity Partners Management LP - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 37 filers reported holding AC IMMUNE SA in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
Avidity Partners Management LP ownership history of AC IMMUNE SA
ValueSharesWeighting
Q3 2023$8,463,930
-1.3%
2,969,800
+2.3%
0.34%
+13.7%
Q2 2023$8,579,187
+1026.7%
2,903,278
+792.2%
0.30%
+1100.0%
Q1 2023$761,436
+14.7%
325,4000.0%0.02%
+78.6%
Q4 2022$663,816
-23.6%
325,400
+18.4%
0.01%
-22.2%
Q3 2022$869,000
-92.6%
274,876
-84.2%
0.02%
-93.1%
Q3 2021$11,673,000
-7.1%
1,739,600
+9.8%
0.26%
-23.8%
Q2 2021$12,561,000
+66.1%
1,584,000
+2.2%
0.34%
-3.1%
Q3 2020$7,564,0001,550,0000.35%
Other shareholders
AC IMMUNE SA shareholders Q3 2022
NameSharesValueWeighting ↓
BVF INC/IL 7,428,379$21,170,8800.57%
Avidity Partners Management LP 2,969,800$8,463,9300.34%
PLATINUM INVESTMENT MANAGEMENT LTD 1,322,462$3,769,0170.15%
Eversept Partners, LP 124,589$355,0790.03%
COHEN LAWRENCE B 12,850$36,6230.02%
Banque Cantonale Vaudoise 80,701$2310.01%
Renaissance Technologies 425,179$1,2120.00%
Handelsbanken Fonder AB 101,064$2880.00%
Tower Research Capital LLC (TRC) 19,638$55,9680.00%
Compagnie Lombard Odier SCmA 10,000$28,5000.00%
View complete list of AC IMMUNE SA shareholders